CITED4 inhibitors are a class of chemicals that influence the protein indirectly by modulating various pathways and processes within the cell. These compounds can exert their influence on signaling cascades or transcriptional regulation in which CITED4 is known to play a role. For instance, curcumin and resveratrol are compounds that interact with a broad range of molecular targets, including transcription factors that could associate with CITED4, thereby potentially modulating its co-regulatory functions.
Furthermore, inhibitors of specific signaling kinases, such as PD98059, SB203580, LY294002, Wortmannin, SP600125, and Rapamycin, can impact the MAPK, PI3K/AKT, and mTOR pathways. Since these signal transduction pathways are pivotal in regulating gene expression, the activity of transcriptional co-regulators like CITED4 could be influenced by such inhibitors. By altering the activation state of transcription factors that CITED4 might interact with, these compounds indirectly affect its function. Additionally, molecules that target the epigenetic regulation of gene expression, such as Trichostatin A and 5-Azacytidine, can also modify the activity of transcriptional co-regulators. By changing the chromatin structure and DNA methylation patterns, these inhibitors may alter the cellular context in which CITED4 operates. Lastly, Kenpaullone, by inhibiting cyclin-dependent kinases, could indirectly influence the cell cycle and transcriptional regulatory mechanisms involving CITED4.It is important to note that these chemicals do not directly inhibit CITED4 but affect the broader cellular environment, signaling pathways, or gene expression mechanisms that CITED4 is associated with. The indirect nature of these inhibitors means that they can affect the activities and interactions of CITED4, potentially altering its role in transcriptional regulation without binding to the protein itself.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate transcription factors and signaling pathways that CITED4 may interact with. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This compound can alter the activity of various transcription factors to which CITED4 might bind. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that can alter ERK pathway signaling, potentially influencing CITED4 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase potentially affecting transcription factors associated with CITED4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can modify AKT signaling, possibly affecting CITED4's role in transcription. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that could influence signaling pathways involving CITED4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, could alter signaling cascades that affect CITED4's interaction with transcription factors. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, potentially affecting cellular processes that CITED4 may influence. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits the Hedgehog signaling pathway, potentially impacting CITED4's role in this pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can modify chromatin structure, potentially influencing CITED4's activity. | ||||||